ArticleExperimental & molecular medicine2020

EGFR/FOXO3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide.

Iwona Anna Ciechomska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.